1.
Atla B, Sarkar RN, Rasaputra M. Clinicopathological and IHC study (estrogen receptors, progesterone receptor, HER2/NEU) in malignant ovarian tumors. Int J Res Med Sci [Internet]. 2016 Dec. 28 [cited 2025 Oct. 15];4(4):1068-73. Available from: https://www.msjonline.org/index.php/ijrms/article/view/651